The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

In Ger­man-on­ly an­nounce­ment, Bay­er in­vests $1.5B in­to na­tive coun­try man­u­fac­tur­ing

4 years ago

NASEM re­leas­es re­port on med­ical sup­ply-chain re­silien­cy

4 years ago

Af­ter 25 years, Hov­ione's CEO will step down; Helsinn gains in­fi­gra­tinib li­cense from Bridge­Bio 

4 years ago

Covid-19 man­u­fac­tur­ing roundup: 9 part­ners to help Bio­vac's man­u­fac­tur­ing ex­pan­sion; Af­ter pro­duc­tion pledges, Covid-19 test de­mand has plum­met­ed

4 years ago

Catal­ent ex­pands in­hala­tion ef­forts in col­lab­o­ra­tion with Texas-based phar­ma

4 years ago
Pharma

Ster­ling builds up its API ca­pac­i­ty with big buy of No­var­tis cam­pus in Ire­land

4 years ago
Pharma

Months af­ter IPO, Ital­ian vial com­pa­ny lands BAR­DA in­vest­ment as gov­ern­ment looks to shore up pan­dem­ic pre­pared­ness

4 years ago

No­vavax dou­bles down on promise to pro­duce 2B Nu­vax­ovid dos­es — this year

4 years ago
R&D
Pharma

Cure­Vac es­tab­lish­es RNA print­er-spe­cif­ic com­pa­ny as light at the end of tun­nel nears

4 years ago
Pharma

Emer­gen­t's trou­bled Bal­ti­more site gets $100M up­grade

4 years ago
Pharma

On a roll, Re­ci­pharm wraps up its sec­ond and third CD­MO ac­qui­si­tions this month

4 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: Scot­tish gov­ern­ment in­vests $27M in Val­neva's Covid-19 man­u­fac­tur­ing; Mod­er­na part­ners with Latin Amer­i­can phar­ma

4 years ago

Mod­er­na ties the knot with Ther­mo Fish­er on a 15-year man­u­fac­tur­ing al­liance, glu­ing a glob­al net­work

4 years ago

Build­ing on CRISPR suc­cess, In­tel­lia inks deal for new man­u­fac­tur­ing fa­cil­i­ty in Waltham, MA

4 years ago
Pharma
Cell/Gene Tx

Man­u­fac­tur­ing re­org at Mer­ck KGaA in­spires a $500M+ in­vest­ment in mR­NA tech

4 years ago
Pharma

mR­NA for all: WHO es­tab­lish­es bio­man­u­fac­tur­ing train­ing hub in Ko­rea

4 years ago
Coronavirus

Chi­nese cell ther­a­py com­pa­ny opens first US man­u­fac­tur­ing site

4 years ago

Mallinck­rodt chalks up CRL to pack­ag­ing and la­bel­ing fa­cil­i­ty strug­gles

4 years ago
Pharma

It looks like the fi­nal round of Emer­gen­t's As­traZeneca Covid-19 dos­es have been re­leased

4 years ago
Pharma

Pub­lic Cit­i­zen ac­cus­es Pfiz­er of build­ing 'patent wal­l' for Covid treat­ment, set­ting up in­equities again

4 years ago
Pharma
Coronavirus

To keep up with de­mand, Sor­ren­to ac­quires ma­jor­i­ty own­er­ship in Covid-19 test man­u­fac­tur­er

4 years ago
Pharma

Ther­mo Fish­er posts the help want­ed sign as it up­grades sin­gle-use man­u­fac­tur­ing ca­pac­i­ty in Penn­syl­va­nia for sec­ond time in two years

4 years ago
Pharma

Re­silience moves Cana­di­an site in­to plas­ma ther­a­pies, as it signs deal with Take­da

4 years ago

With $200M in new cash, Syn­thego wants to be­come the man­u­fac­tur­ing bedrock for CRISPR. But where are its cus­tomers?

4 years ago
Financing
Startups
First page Previous page 57585960616263 Next page Last page
A service from the Financial Times